US HB4385 | 2017-2018 | 115th Congress
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on November 14 2017 - 25% progression, died in committee
Action: 2017-11-17 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on November 14 2017 - 25% progression, died in committee
Action: 2017-11-17 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Responsibility in Drug Advertising Act of 2017
Title
Responsibility in Drug Advertising Act of 2017
Sponsors
Rep. Rosa DeLauro [D-CT] |
History
Date | Chamber | Action |
---|---|---|
2017-11-17 | House | Referred to the Subcommittee on Health. |
2017-11-14 | House | Referred to the House Committee on Energy and Commerce. |
2017-11-14 | House | Introduced in House |
Subjects
Drug safety, medical device, and laboratory regulation
Health
Marketing and advertising
Prescription drugs
Health
Marketing and advertising
Prescription drugs
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/115th-congress/house-bill/4385/all-info |
Text | https://www.congress.gov/115/bills/hr4385/BILLS-115hr4385ih.pdf |